The table below shows Celldex Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
$200.00K
$200.00K
$300.00K
$100.00K
$100.00K
$200.00K
Gross profit
-
-
-
-
-
-
R&D
$245.07M
$163.55M
$118.01M
$82.26M
$53.31M
$42.53M
SG&A
CLDX annual revenue (10-K history)
Celldex Therapeutics, Inc. reported annual revenue of $1.54M for fiscal year 2025. That is down 78.0% from $7.02M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $6.79M (FY 2016) to $1.54M. Figures come from the company's audited annual reports as filed with the SEC.
